![]() |
The steep decline since the middle of May accelerated to the downside at the end of last week. But the interesting and disturbing thing has been the reluctance of it to be reflected by an oversold condition. One would expect to see the VIX go to quite high numbers, and the moving averages of the Arms Index to become dramatically oversold, yet we have seen neither occur. This is indicating a lack of panic, yet, and usually a decline as long and as steep as this one ends in capitulation. The suggestion, therefore, is that it is not over.
This has all been a down leg within the bigger bear move that we have been observing since last October, and it does not seem to yet be over. We will get a better rally, and probably very soon, but remember, it will be a bear market rally. Bear market rallies are for selling. To view a larger version of these charts (in some browsers), after clicking on the "larger image" link below the chart, mouse over the lower-right area of the chart until the icon with four arrows appears. Then click on that icon.
Barrick Gold: Buy
The two volume-adjusted moving averages that overlie the price plot have crossed to the positive side, and so has the moving average convergence/divergence (MACD) across the top of the chart. I would expect a lighter-volume pullback over the next week or so, and would use such a pullback as a buying opportunity. (To do my Equivolume charting, as in the charts that appear in this column, I use a charting program called MetaStock. To learn more about this method, read my series of columns, Trading With Equivolume.) Newmont Mining: Buy
Newmont Mining (NEM - commentary - Cramer's Take) is another gold stock that has started to act well in the last few days. As with Barrick, we have a volume move through resistance. We have a wide enough base to support a substantial move. The MACD has crossed to the plus side, and so have the two moving average lines. Here, too, it would not be surprising to see a lighter-volume pullback before going higher. Consequently, I am inclined to hold back a bit, rather than jump in at this level. Brucker Biosciences: Buy
Brucker Biosciences (BRKR - commentary - Cramer's Take) broke out to the upside almost two weeks ago. Notice the heavy volume and the widening trading ranges as it moved through the resistance level. Since then it has drifted slightly lower with lighter trading, giving us a very typical small triangular formation. This appears to be giving us an opportunity to use the technique of buying on a stop-buy order. Placing a buy just above the buy line indicated, and following the line down by moving the stop lower if necessary, sets up the situation in which the stock gets bought as soon as strength resumes, and it penetrates that line. If it continues lower, and does not act well, the stock never gets bought. Celanese: Short
The sharp continued drop in Celanese (CE - commentary - Cramer's Take) Monday may have overdone it on the downside for the short-term, but longer-term, the stock looks as though it is headed lower. Three days ago, it broke a very important support level with heavy volume. It has penetrated both the steeper and the less-steep uptrend lines. The MACD went negative a week ago, and the two moving-average lines are just crossing over. I would look for a rally on light volume as an opportunity to put on a short position.
At time of publication, Arms had no positions in the stocks mentioned.Richard Arms is a renowned stock market technician who invented the Arms Index (often referred to as the TRIN), which has become a mainstay of market analysis, appearing in The Wall Street Journal and Barron's. Arms also developed the widely used technical method Equivolume Charting. Since 1996, he has been publishing the Arms Advisory newsletter for money managers and financial institutions. He also has authored Stop and Make Money: How to Profit in the Stock Market Using Volume and Stop Orders, Profits in Volume, Volume Cycles in the Stock Market, Trading Without Fear and The Arms Index, and has been honored with the Market Technicians' Award for Lifetime Contribution to Technical Analysis. Under no circumstances does the information in this commentary represent a recommendation to buy or sell stocks. Richard appreciates your feedback; click here to send him an email. TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||